Sign In
Buy ATI
$197.80
-2.04 (-1.02%)
At Close: Jul 24, 2026
New Strong Sell Stocks for November 22nd
04:56am, Friday, 22'nd Nov 2024
ATI, AKBA and ALTG have been added to the Zacks Rank #5 (Strong Sell) List on November 22, 2024.
New Strong Sell Stocks for November 18th
05:05am, Monday, 18'th Nov 2024
ATI, BALY and KOF have been added to the Zacks Rank #5 (Strong Sell) List on November 18, 2024.
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
07:15am, Thursday, 14'th Nov 2024
Overwhelming shareholder support in favour of take-private transaction with Aditxt Studies presented at IDWeek 2024™ demonstrate ATI-1701 provides full protection against lethal tularemia in animal
The Achievement Continues the Company's Streak in Earning the Rating Annually Since the Program Debuted in 2019 BOLINGBROOK, Ill. , Nov. 13, 2024 /PRNewswire/ -- ATI Physical Therapy ("ATI" or the "
ATI announces sale of precision rolled strip operations to Ulbrich
04:45pm, Wednesday, 06'th Nov 2024
Sharpens focus on strategic aerospace and defense markets, streamlines operations DALLAS , Nov. 6, 2024 /PRNewswire/ -- ATI Inc. (NYSE: ATI) announced it completed the sale of its precision rolled str
ATI Physical Therapy Reports Third Quarter 2024 Results
04:05pm, Monday, 04'th Nov 2024
BOLINGBROOK, Ill. , Nov. 4, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. (NYSE: ATIP) ("ATI" or the "Company"), a nationally recognized outpatient physical therapy provider in the United States, t
Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
07:15am, Thursday, 31'st Oct 2024
Demonstrated safety and efficacy across multiple Phase 2 and Phase 3 studies Appili provides update on Aditxt transaction and encourages shareholders to vote their shares as soon as possible for the N
ATI's Earnings Miss Estimates in Q3, Revenues Increase Y/Y
08:10am, Wednesday, 30'th Oct 2024
ATI saw higher year-over-year sales in aerospace and defense in the third quarter.
ATI Inc (ATI) Q3 2024 Earnings Call Transcript
12:09pm, Tuesday, 29'th Oct 2024
ATI Inc (NYSE:ATI ) Q3 2024 Results Conference Call October 29, 2024 8:30 AM ET Company Participants David Weston - Vice President of Investor Relations Kim Fields - President, CEO & Director Don Newm
Allegheny Technologies (ATI) Q3 Earnings and Revenues Lag Estimates
09:46am, Tuesday, 29'th Oct 2024
Allegheny Technologies (ATI) came out with quarterly earnings of $0.60 per share, missing the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.55 per share a year ago.
ATI Announces Third Quarter 2024 Results
07:30am, Tuesday, 29'th Oct 2024
Ninth consecutive quarter with sales in excess of $1 billion Q3 2024 sales of $1.05 billion Q3 2024 net income attributable to ATI of $82.7 million, or $0.57 per share Aerospace & defense represent 62
Allegheny Technologies (ATI) Reports Next Week: Wall Street Expects Earnings Growth
11:05am, Tuesday, 22'nd Oct 2024
Allegheny Technologies (ATI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ATI Physical Therapy to Announce Third Quarter 2024 Financial Results
12:00pm, Monday, 21'st Oct 2024
BOLINGBROOK, Ill. , Oct. 21, 2024 /PRNewswire/ -- ATI Physical Therapy, Inc. – ("ATI" or the "Company") (NYSE: ATIP), a nationally recognized outpatient physical therapy provider in the United State
Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024
07:15am, Thursday, 17'th Oct 2024
ATI-1701 provides full protection against lethal tularemia in animal models after one year Company to provide update on tularemia vaccine candidate ATI-1701 and present new data on efficacy Presentati
Allegheny Technologies (ATI) Exceeds Market Returns: Some Facts to Consider
07:21pm, Wednesday, 16'th Oct 2024
Allegheny Technologies (ATI) reachead $63.02 at the closing of the latest trading day, reflecting a +0.75% change compared to its last close.
